Daniel B. Soland

VP; President, Chiron Vaccines, CHIRON CORP.

Companies

Acadia PharmaceuticalsBoard member Mar 24, 2015 to now¹
DBV TechnologiesBoard member Jan 11, 2021 to Aug 3, 2023²
Idera SoftwareChief operating officer Jan 5, 2021 to Jul 7, 2022³
KalVista Pharmaceuticals, Inc.Board member Apr 23, 2019 to Oct 1, 2021⁴
ViroPharmaChief operating officer Jun 17, 2008 to Jan 28, 2014⁵
ViroPharmaVP, Chief Commercial Officer Nov 7, 2006 to Jan 15, 2008⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Acadia Pharmaceuticals ACAD44,041 shares⁷$863.6K at $19.61May 29, 2025
DBV Technologies DBVT20,000 shares⁸$179.7K at $8.98Aug 1, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

May 29, 2025Exercised options 9,387 shares of Acadia Pharmaceuticals⁷
May 29, 2024Exercised options 6,652 shares of Acadia Pharmaceuticals⁹
Aug 1, 2023Bought 15,000 shares at $1.62 of DBV Technologies⁸
Jun 1, 2023Exercised options 8,552 shares of Acadia Pharmaceuticals¹⁰
Jun 7, 2022Exercised options 6,391 shares of Acadia Pharmaceuticals¹⁰
Jun 22, 2021Exercised options 3,059 shares of Acadia Pharmaceuticals¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAcadia Pharmaceuticals, Board member
2
SEC EDGARDBV Technologies, Board member
3
SEC EDGARIdera Software, Chief operating officer
4
SEC EDGARKalVista Pharmaceuticals, Inc., Board member
5
SEC EDGARViroPharma, Chief operating officer
6
SEC EDGARViroPharma, VP, Chief Commercial Officer
7
SEC EDGARAcadia Pharmaceuticals shares after the filing of May 29, 2025
8
SEC EDGARDBV Technologies shares after the filing of Aug 1, 2023
9
SEC EDGARForm 4 filed May 31, 2024
10
SEC EDGARForm 4 filed Jun 5, 2023